Lignite
1. Samsel A and Seneff S. Glyphosate’s Suppression of Cytochrome P450 Enzymes and Amino Acid Biosynthesis by the Gut Microbiome: Pathways to Modern Diseases. Entropy 2013, 15:1416-1463
2. Gildea JJ, Roberts DA, Bush Z (2016) Protection against Gluten-mediated Tight Junction Injury with a Novel Lignite Extract Supplement. J Nutr Food Sci 6: 54
IMMULOX
4. Bishop GA, Haxhinasto SA, Stunz LL, Hostager BS. Antigen-specific B-lymphocyte activation. Crit Rev Immunol, 2003;23(3):149-97.
10. Francis, G. L., et al., Purification and partial sequence analysis of insulin-like growth factor-l (IGF-1) from bovine colostrum. Biochem. J. 1986. 233: p. 207-213.
11. Francis, G. L., et al., Insulin-like growth factors-l (IGF-1) and 2 (IGF-2) in bovine colostrum. Biochem. J. 1988. 251:p. 95-103.
16. Lawton, J. W. M., et al., Interferon synthesis by human colostral leukocytes. Arch. Dis. Childhood. 1979. 54: p.127-130.
18. Pizza G, Meduri R, De Vinci C, et al. Transfer factor prevents relapses in herpes keratitis patients: a pilot study. Biotherapy, 1994;8(1):63-8.
19. Pizza G, Viza D, De Vinci C, et al. Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses. Biotherapy, 1996;9(1-3):67-72.
20. Meduri R, Campos E, Scorolli L, et al. Efficacy of transfer factor in treating patients with recurrent ocular herpes infections. Biotherapy, 1996;9(1-3):61-6.
21. Oda, S., et al., Insulin-like growth factor-l (IGF-1), growth hormone (GH), insulin and glucagon concentrations in bovine colostrum and in plasma of dairy cows and neonatal calves around parturition. Comp. Biochem. Physiol. 1989. 94A(4): p. 805-808.
23. Palmer,E.L. et al. Antiviral Activity of Colostrum and Serum Immunoglobulins A and G. J. Med. Virol. 5:123-129. 1980.
24. Orzechowska B, Janusz M, Domaraczenko B, Blach-Olszewska Z. Antiviral effect of proline-rich polypeptide in murine resident peritoneal cells. Acta Virol, 1998;42(2):75-8.
25. Van Hooijdonk AC, Kussendrager KD, Steijns JM. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defense. Br J Nutr, 2000;84 (Suppl 1):S127-34.
26. Ushijima H, Dairaku M, Honnma H, et al. [Immunoglobulin components and anti-viral activities in bovine colostrum.] Kansenshogaku Zasshi, 1990;64(3):274-9.
33. Clark, Daniel G. and Wyatt, Kaye. Colostrum, Life’s First Food. Salt Lake City:CNR Publications. 1996.
34. Jensen, Bernard. Colostrum: Man’s First Food, The White Gold Discovery. Escondido:Bernard Jensen, 1993.
38. Kohl, S. et al., Human colostral cytotoxicity: antibody-dependent cellular cytotoxicity against herpes simplex infected by colostral cells. Journal of Clinical Laboratory Immunology, 1, pp. 221-224.
SUSTAMINE
4. Harris, RC, et al., NBH: L-glutamine absorption is enhanced after ingestion of L-alanylglutamine compared with the free amino acid or wheat protein. Nutr Res 2012, doi:10.1016/j. nutres.2013.02.003.
5. Hoffman, JR, Stavsky H, Falk B: The effect of water restriction on anaerobic power and vertical jumping height in basketball players. Int J Sports Med 1995, 16:214-218.
6. Cruzat, V.F., M.M. Rogero, and J. Tirapegui, Effects of supplementation with free glutamine and the dipeptide alanyl-glutamine on parameters of muscle damage and inflammation in rats submitted to prolonged exercise. Cell Biochem Funct, 2010. 28(1): p. 24-30.
10. Castell, L., et al., Granule localization of glutaminase in human neutrophils andthe consequence of glutamine utilization for neutrophil activity. J Biol Chem,2004. 279(14): p. 13305-10.
12. Miller, A.L., Therapeutic considerations of L-glutamine: a review of the literature. Altern Med Rev, 1999. 4(4): p. 239-48.
13. Welbourne, T.C., Increased plasma bicarbonate and growth hormone after an oral glutamine load. Am J Clin Nutr, 1995. 61(5): p. 1058-61.
14. Braga-Neto, M.B., et al., Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro. Dig Dis Sci, 2008. 53(10): p. 2687-96.
15. Roth, E., Nonnutritive effects of glutamine. J Nutr, 2008. 138(10): p. 2025S-2031
16. Castell, L., et al., Granule localization of glutaminase in human neutrophils and the consequence of glutamine utilization for neutrophil activity. J Biol Chem, 2004. 279(14): p. 13305-10.
17. Newsholme, E.A., B. Crabtree, and M.S. Ardawi, Glutamine metabolism inlymphocytes: its biochemical, physiological and clinical importance. Q J ExpPhysiol, 1985. 70(4): p. 473-89.
21. Man-xi Bai, et. al., Effects of Alanyl-Glutamine on gut barrier function. BasicNutritional Investigation. 1996, 12(11,12): p.793-796.
22. Y. Li, et al., Clinical trial: prophylactic intravenous alanyl-glutamine reducesthe severity of gastrointestinal toxicity induced by chemotherapy – arandomized crossover study. Alimentary Pharmacology & Therapeutics. 2008,30: p.452-458.
PepZin
1. Matsukura, T; Takahashi, T; Nishimura, Y; Ohtani, T; Sawada, M; Shibata, K: Chem. Pharm. Bull. (1990), 38(11), 3140-6.
2. Matsukura, T.; Tanaka, H: Biochemistry (Moscow) (2000), 65(7), 817-823.
3. Walsh, CT; Sandstead, HH; Prasad, AS; Newberne, PM; Fraker, PJ: Environ. Health Perspect (1994), 102 Suppl 2, 5-46.
4. Yamakawa, A: Showa Igakkai Zasshi. (1975), 35(2), 113-126.
5. Cho, CH: Drug Dev. Res. (1989), 17(3), 185-197.
6. Yoshikawa, T; Naito, Y; Tanigawa, T; Yoneta, T; Kondo, M: Biochim. Biophys. Acta (1991), 1115(1), 15-22.
7. Cho, CH; Luk, CT; Ogle, CW: Life Sci. (1991), 49(23), PL189-PL194.
8. Arakawa, T; Satoh, H; Nakamura, A; Nebiki, H; Fukuda, T; Sakuma, H; Nakamura, H; Ishikawa, M; Seiki, M; Kobayashi, K: Dig. Dis. Sci. (1990), 35(5), 559-66.
9. Seiki, M; Aida, H; Ueki, S; Yoneta, T; Takemasa, T; Hori, Y; Morita, H; Chaki, K; Tagashira, E: Nippon Yakurigaku Zasshi (1992), 100(2), 165-72.
10. Sunairi, M; Tanaka, N; Kuwayama, H; Nakajima, M: Yakuri to Chiryo (1994), 22(9), 3771-3775.
11. Seiki, M; Aida, H; Mera, Y; Arai, K; Toyama, S; Furuta, S; Morita, H; Hori, Y; Yoneta, T; Tagashira, E: Nippon Yakurigaku Zasshi (1992), 99(4), 255-63.
12. Matsuda, K; Mera, Y; Wada, H; Aruga, H; Saik, Y; Taniguchi, Y: Arzneim. Forsch. (1991), 41(10), 1036-1041.
13. Miyoshi A, et al. Clinical evaluation of Z-103 on gastric ulcer - a multicenter double-blind comparative study with cetraxate hydrochloride. Jpn PharmTher 1992;20(1):199-223.
14. Sugiyama T; Tanaka H; Kawai S: Journal of Bone and Mineral Metabolism (2000), 18(6), 335-338.
15. Ikui, A; Ikeda M; Yoshikawa T; Kudo I; Onoda K; Kida A: Jibiinkou (1999), 92(7), 801-804.
16. Takagi, H; Nagamine, T; Abe, T; Takayama, H; Sato, K; Otsuka, T; Kakizaki, S; Hashimoto, Y; Matsumoto, T; Kojima, A; Takezawa, J: Suzuki K; Sato S; Mori M. Journal of Viral Hepatitis (2001) 8(5) 367-71.
17. Takeda, S; Yoshikawa, T; Morita, Y; Yoshida, N; Kondo, M: J. Clin. Biochem. Nutr. (1999), 26(3), 213-225.
18. Tameyasu, T; Yamada, M; Tanaka, M; Takahashi, S: Japanese Journal of Physiology (2002), 52, 111-120.
19. Yoshikawa, T; Yamaguchi, T; Yoshida, N; Yamamoto, H; Kitazumi, S; Takahashi, S; Naito, Y; Kondo, M: Digestion (1997), 58(5), 464-468.
20. Watanabe, S; Wang, XE; Yoneta, T; Seto, K; Sato, N: Gastroenterology (1997), 112, 327A.
21. Katayama, S; Nishizawa, K; Hirano, M; Yamamura, S; Momose, Y: J. Pharm. Pharm. Sci. (2000), 3(1), 114-117.
22. Nishimura, Y; Yamagishi, Y; Ando, K; Saito, T; Matsukura, T: Biomed. Res. Trace Elem. (2001), 12(2), 159-167.
23. Boldyrev, AA; Gallant, SC; Suhkich, GT: Biosci. Rep. (1999), 19 (6), 581-7.
24. Misawa T, et al. Clinical study of Z-103 - clinical effects on gastric ulcer and influence on endocrine function. Jpn PharmTher 1992; 20(1):245-254.
25. Kuwayama H, et al. Polaprezinc. Nippon Rinsho 2002 Feb; 60 Suppl 2:717-720.
26. Hiraishi H, et al. Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro. Aliment Pharmacl Ther 1999;13:261-269.
27. Kato S, Nishiwaki H, et al. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate. Dig Dis Sci 1997;42(10):2156-2163.
28. Naito Y, et al. Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and TNF-alpha expression in rats with aspirin-induced gastric mucosal injury.
Dig Dis Sci 2001;46(4):845-851.
QUERCETIN
1. "Influence of Quercetin Supplementation on Disease Risk Factors in Community-Dwelling Adults" in Journal of the American Dietetic Association (2011)
2. Suzuki T, Hara H (2009) Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J Nutr 139: 965–974.
3. .^cIzzi V, Masuelli L, Tresoldi I, Sacchetti P, Modesti A, Galvano F, Bei R (2012). "The effects of dietary flavonoids on the regulation of redox inflammatory networks". Frontiers in bioscience (Landmark edition). 17 (7): 2396–2418. doi:10.2741/4061. PMID 22652788.
4. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009). "Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)". Annu. Rev. Immunol. 27: 621–68. doi:10.1146/annurev.immunol.25.022106.141627. PMC 2996236 . PMID 19302049.
RUTIN
4“Rutin has intestinal anti-inflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis” In Pharmacological Research (Dec. 2014)
QING DAI
1. Suzuki H1, Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis. World J Gastroenterol. 2013 May 7;19(17):2718-22. doi: 10.3748/wjg.v19.i17.2718. http://www.ncbi.nlm.nih.gov/pubmed/23674882
2. http://cmjournal.biomedcentral.com/articles/10.1186/s13020-015-0061-x
CAT’S CLAW
1. Hardin SR. Cat's claw: an Amazonian vine decreases inflammation in osteoarthritis. Complement Ther Clin Pract. 2007 Feb;13(1):25-8.
2. Sandoval M, Charbonnet RM, Okuhama NN, et al. Cat's claw inhibits TNFalpha production and scavenges free radicals: role in cytoprotection. Free Radic Biol Med. 2000;29(1):71-78
Slippery Elm
Bock S. Integrative medical treatment of inflammatory bowel disease. Int J Integr Med. 2000;2:21-29.
Brown AC, Hairfield M, Richards DG, McMillin DL, Mein EA, Nelson CD. Medical nutrition therapy as a potential complementary treatment for psoriasis -- five case reports. Altern Med Rev. 2004;9:297-307.
Hawrelak JA, Myers SP. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. J Altern Complement Med. 2010;16:1065-71.
Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther. 2002;16:197-205.
Rakel D. Rakel: Integrative Medicine, 3rd ed. Philadelphia, PA: Elsevier Saunders; 2012:43.
Rotblatt M, Ziment I. Evidence-based Herbal Medicine. Philadelphia, Penn: Hanley & Belfus, Inc.;2202:337-338.
https://umm.edu/health/medical/altmed/herb/slippery-elm
MARSHMALLOW
https://umm.edu/health/medical/altmed/herb/marshmallow
Basch E, Ulbricht C, Hammerness P, Vora M. Marshmallow (Althaea officinalis L.) monograph. J Herb Pharmacother. 2003;3(3):71-81.
Buechi S, Vogelin R, von Eiff MM, Ramos M, Melzer J. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch Komplementarmed Klass Naturheilkd. 2005 Dec;12(6):328-332.
Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integrative Medicine
Communications; 2000:244-248.
Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications; 1998:99.
Drake PM, de Moraes Madeira L, Szeto TH, Ma JK. Transformation of Althaea officinalis L. by Agrobacterium rhizogenes for the production of transgenic roots expressing the anti-HIV microbicide cyanovirin-N. Transgenic Res. 2013; 22(6):1225-1229.
Franz G. Polysaccharides in pharmacy. Current applications and future concepts. Planta Med. 1989; 55:493-497.
Newall C, Anderson L, Phillipson J. Herbal Medicines: A Guide for Health-care Professionals. London, England: Pharmaceutical Press; 1996:188.
Nosál'ova G, Strapková A, Kardösová A, Capek P, Zathurecký L, Bukovská E. [Antitussive action of extracts and polysaccharides of marsh mallow (Althea officinalis L., var. robusta)] [German]. Pharmazie. 1992;47(3): 224-226.
Rakel: Integrative Medicine, 3rd ed. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2012.
Schulz V, Hansel R, Tyler V. Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 4th ed. Berlin, Germany: Springer; 2000:29,182.
Sutovska M, Nosalova G, Franova S, Kardosova A. The antitussive activity of polysaccharides from Althaea officinalis l., var. Robusta, Arctium lappa L., var. Herkules, and Prunus persica L., Batsch. Bratisl Lek Listy. 2007;108(2):93-99.